PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24434152-0 2014 PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression. Cisplatin 29-38 keratin 10 Homo sapiens 101-106 26125866-0 2015 Recombinant adenovirus-mediated overexpression of PTEN and KRT10 improves cisplatin resistance of ovarian cancer in vitro and in vivo. Cisplatin 74-83 keratin 10 Homo sapiens 59-64 26125866-2 2015 Overexpression of phosphatase and tensin homolog (PTEN) has been shown to preserve the cisplatin-resistance of ovarian cancer cells, while cisplatin-induced keratin 10 (KRT10) overexpression mediates the resistance-reversing effect of PTEN. Cisplatin 139-148 keratin 10 Homo sapiens 157-167 26125866-2 2015 Overexpression of phosphatase and tensin homolog (PTEN) has been shown to preserve the cisplatin-resistance of ovarian cancer cells, while cisplatin-induced keratin 10 (KRT10) overexpression mediates the resistance-reversing effect of PTEN. Cisplatin 139-148 keratin 10 Homo sapiens 169-174 26125866-3 2015 However, whether overexpression of PTEN or KRT10 can improve the cisplatin resistance of ovarian cancer in vivo has not been investigated. Cisplatin 65-74 keratin 10 Homo sapiens 43-48 26125866-6 2015 The effects of overexpression of PTEN and KRT10 on cisplatin resistance of ovarian cancer cells were examined using the 3(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide (MTT) and TdT-mediated dUTP nick-end labeling (TUNEL) assays in vitro. Cisplatin 51-60 keratin 10 Homo sapiens 42-47 26125866-8 2015 The MTT assay showed that recombinant adenovirus-mediated overexpression of KRT10 and PTEN enhanced the proliferation inhibition effect of cisplatin on C13K cells. Cisplatin 139-148 keratin 10 Homo sapiens 76-81 26125866-9 2015 Recombinant adenovirus-mediated overexpression of KRT10 and PTEN also increased the cisplatin-induced apoptosis rate of C13K cells. Cisplatin 84-93 keratin 10 Homo sapiens 50-55 26125866-10 2015 Furthermore, recombinant adenovirus-mediated overexpression of KRT10 and PTEN enhanced the inhibitory effect of cisplatin on C13K xenograft tumor growth. Cisplatin 112-121 keratin 10 Homo sapiens 63-68 26125866-11 2015 Thus, recombinant adenovirus-mediated overexpression of KRT10 and PTEN may improve the cisplatin resistance of ovarian cancer in vitro and in vivo. Cisplatin 87-96 keratin 10 Homo sapiens 56-61 24434152-8 2014 KRT10 was identified as a differently expressed protein in cisplatin-treated C13K/PTEN cells. Cisplatin 59-68 keratin 10 Homo sapiens 0-5 24434152-9 2014 Further study confirmed that cisplatin could induce upregulation of KRT10 mRNA and protein in C13K/PTEN cells and there was a directly interaction between KRT10 and PTEN. Cisplatin 29-38 keratin 10 Homo sapiens 68-73 24434152-9 2014 Further study confirmed that cisplatin could induce upregulation of KRT10 mRNA and protein in C13K/PTEN cells and there was a directly interaction between KRT10 and PTEN. Cisplatin 29-38 keratin 10 Homo sapiens 155-160 24434152-10 2014 Forced expression of KRT10 in C13K cells also enhanced cisplatin-induced proliferation inhibition and apoptosis of C13K cells. Cisplatin 55-64 keratin 10 Homo sapiens 21-26 24434152-11 2014 In addition, KRT10 siRNA blocked cisplatin-induced proliferation inhibition of C13K/PTEN cells. Cisplatin 33-42 keratin 10 Homo sapiens 13-18 24434152-12 2014 In conclusion, our data demonstrate that KRT10 is a downstream molecule of PTEN which improves cisplatin-resistance of ovarian cancer and forced KRT10 overexpression may also act as a therapeutic method for overcoming MDR in ovarian cancer. Cisplatin 95-104 keratin 10 Homo sapiens 41-46